510(k) K032850
K032850 is an FDA 510(k) premarket notification submitted by Immco Diagnostics, Inc. for the device "IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGG)". The FDA issued a decision of Substantially Equivalent on Mar 18, 2004. The device falls under product code NBT (Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae)), a Class II device regulated under 21 CFR 866.5785. Immco Diagnostics, Inc. has 54 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 18, 2004
- Date Received
- Sep 12, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae)
- Device Class
- Class II
- Regulation Number
- 866.5785
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Immco Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.